Epithalon vs Thymalin: Differences, Research & How They Pair

Epithalon and Thymalin are the two most-studied Khavinson peptide bioregulators, but they target different organs. Epithalon is a synthetic pineal tetrapeptide (Ala-Glu-Asp-Gly) studied for telomerase activation and circadian/melatonin regulation; Thymalin is a natural thymus polypeptide complex studied for immune restoration. Same bioregulation tradition, different organ target — and the two were paired in Khavinson’s landmark life-extension cohort.

TL;DR: Epithalon is the longevity/circadian peptide — a single defined synthetic sequence (~390 Da) that upregulates hTERT and normalizes pineal melatonin output, dosed ~5–10 mg SubQ daily for 10–20 days, 2–3× per year. Thymalin is the immune peptide — a thymus-derived complex (not one sequence) dosed ~10 mg/day for 5–10 days. They are not competitors: the classic Khavinson protocol runs the pineal and thymus peptides together, and the strongest human signal in the whole family (PMID 14523363) came from combining them. Key nuance — that cohort used Epithalamin, the natural pineal extract, not synthetic Epithalon. Neither is FDA-approved; both are research-use-only in the US.

Research-use & affiliate disclosure: VialBase publishes independent educational information for research and harm-reduction purposes only. Nothing here is medical advice, a prescription, or an endorsement to use any compound in humans. Neither Epithalon nor Thymalin is approved by the U.S. FDA; both are sold for research purposes only. VialBase may earn an affiliate commission from the vendor links in the “Where to Buy” section, at no additional cost to you; this does not influence our research-based editorial coverage. Consult a qualified healthcare professional before making any health decision.

At a Glance

The fastest way to see how the two compare. Every value below is drawn from the VialBase compound profiles; where the source notes do not specify a value, that is stated rather than guessed.

One-line read: same Khavinson bioregulation tradition, two different organs and two different molecular formats. Epithalon is the synthetic, single-sequence longevity/circadian peptide; Thymalin is the natural, multi-peptide immune-restoration complex. They overlap less than they complement.

What Is Epithalon?

Epithalon (also spelled Epitalon) is a synthetic four-amino-acid peptide with the sequence Ala-Glu-Asp-Gly (alanine–glutamic acid–aspartic acid–glycine), a molecular weight of about 390.35 Da, and an estimated half-life of roughly 30 minutes based on limited pharmacokinetic data. It was developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology as the synthetic counterpart to epithalamin, a naturally occurring bioregulator extracted from the pineal gland. See the full profile at epithalon.

Its signature mechanism is activation of telomerase — specifically upregulation of hTERT (the catalytic subunit) — leading to telomere elongation in normal somatic cells. Beyond telomere biology, it is reported to stimulate pineal function and normalize melatonin synthesis (relevant in aged individuals where pineal calcification reduces melatonin output), restore circadian rhythms, and act as a direct antioxidant. It is categorized as a longevity/anti-aging compound and is usually discussed as a standalone longevity peptide — described in peptide literature as supporting “telomere support, circadian reset; anti-aging and endocrine balancing.” Most of its evidence base originates from Russian institutions over more than three decades, with recent international validation of its telomerase-activating properties (PMID 40908429).

What Is Thymalin?

Thymalin is a thymus bioregulator peptide complex that restores thymus function, supports immune-cell (T-cell) education, and modulates immune overactivation. Unlike Epithalon, it is not a single defined molecule — it is a tissue-derived mixture of thymic peptides, placing it in the “natural polypeptide complex” (Cytomax-type) category rather than the “synthetic single-sequence” (Cytogen-type) category. Its active KE and EW dipeptide fractions have been characterized at the gene-expression level (PMID 37686182), which is part of what bridges the natural-extract form to the synthetic short-peptide form. See the full profile at thymalin.

It is described as one of the oldest peptide bioregulators in clinical use, with a strong reported safety record, commonly used in elderly patients for immune revitalization and a fixture in nearly all immune and cancer-support stacks. Reported activities span immune-system reboot, T-cell balance and cytokine regulation, anti-inflammation, thymic rejuvenation, circadian-rhythm support, thyroid (T3/T4) conversion support, and genomic-stability/longevity effects. Its track record is real and long — but, like the rest of the class, it is largely Russian-language and below modern FDA-grade rigor.

Key Differences

Epithalon and Thymalin are easy to lump together — both are short-course Khavinson bioregulators dosed in pulsed cycles, both are sold as research compounds, both are SubQ, and both even touch “longevity” and “circadian” language. But four differences actually matter.

1. Composition — synthetic single sequence vs natural complex

This is the cleanest dividing line. Epithalon is a single, defined synthetic peptide (Ala-Glu-Asp-Gly, ~390 Da) — one known sequence, reproducible, and relatively easy to verify by HPLC. Thymalin is a natural polypeptide complex — a mixture of thymus-derived peptides with no single defined sequence (though its active KE/EW dipeptide fractions have been isolated and studied; PMID 37686182). A research-grade Epithalon lot is therefore easier to confirm for identity and purity than a tissue-extract complex like Thymalin, where composition can vary by manufacturer.

2. Organ target — pineal vs thymus

Epithalon is a pineal peptide; Thymalin is a thymus peptide, and that single fact drives most of the downstream difference in research focus. The pineal governs melatonin and circadian timing, so Epithalon’s reported effects cluster around telomere maintenance, melatonin/sleep, and circadian reset; the thymus governs T-cell maturation, so Thymalin’s cluster around immune restoration, T-cell balance, and inflammation control.

3. Mechanism emphasis

Both sit within Khavinson’s peptide-bioregulation hypothesis — that very short peptides nudge a tissue’s gene expression back toward a younger pattern — but the emphasized mechanism differs:

Read this way, Epithalon leans telomere + circadian + antioxidant, while Thymalin leans immune + thymic + anti-inflammatory. Both invoke epigenetic/gene-expression modulation as the underlying mechanism, but the organ they act on is different.

4. Depth of evidence — the honest comparison

Both are the best-supported members of the Khavinson family, which is exactly why this comparison exists — but their evidence has different shapes:

• Epithalon has the most research overall and the most international validation: 35+ years of study plus recent in-vitro work from Western groups confirming telomerase activation (PMID 40908429) and antioxidant tissue repair (PMID 40493162).
• Thymalin has the longer clinical track record inside Russian bioregulatory medicine, with a strong reported safety profile across decades of use in elderly/immune patients, and active-fraction mechanistic characterization (PMID 37686182).

Neither has an FDA-registered clinical trial, and the great majority of the human evidence for both is Russian-language and below modern FDA standards. That caveat applies to everything that follows.

The Evidence — Honestly Graded

Here is the honest split between what is human, what is animal, what is in-vitro, and how strong each tier is.

The landmark human cohort (and the Epithalamin nuance)

The single strongest human outcome in the entire Khavinson family is Khavinson & Morozov’s 6–8-year cohort of 266 older adults (PMID 14523363), in which the pineal and thymus peptides — given separately and together — reduced mortality versus controls. The combined arm cut mortality roughly 2.5-fold, exceeding either agent alone (Thymalin ~2.0–2.1×; the pineal peptide ~1.6–1.8×), and a subgroup dosed with both annually for six years reached a 4.1-fold reduction. This is the result the entire “pineal + thymus” pairing rests on.

The honest nuance you must not skip: that cohort used Epithalamin — the natural pineal-gland extract — not synthetic Epithalon. Epithalon (Epitalon) is the synthetic tetrapeptide successor built to reproduce epithalamin’s signal, so a cited “Epithalon cut mortality 2.5×” borrows a result generated by the natural extract paired with Thymalin. Animal work supports that the synthetic short peptides reproduce the extract effects on lifespan and tumour incidence (CBA mice; PMID 11163623) — but the headline human number is an Epithalamin number, not an Epithalon one. Treat it as strong supporting evidence for the pairing, not direct proof of the synthetic compound. (The underlying geroprotective data sits in the Russian-language Adv Gerontol report, PMID 12577695; the design principle behind both forms is in Khavinson’s taxonomy monograph, PMID 12374906.)

Telomere claims (Epithalon) vs clinical track record (Thymalin)

The most-cited modern, international Epithalon result is a 2025 in-vitro study (PMID 40908429) showing dose-dependent telomere extension in normal human epithelial and fibroblast cells via hTERT and telomerase activation, while cancer cell lines (21NT, BT474) extended telomeres through a different route — Alternative Lengthening of Telomeres (ALT). That is genuine, quantitative, Western-published validation — but it is in-vitro, not a human telomere-length trial, and long-term effects of telomerase activation in people are not characterized. Thymalin’s support is the inverse shape: thinner on modern in-vitro mechanism, deeper on decades of clinical use with a strong reported safety record; its active KE/EW dipeptide fractions have been characterized at the gene-expression level (PMID 37686182), and in the same cohort it independently reduced mortality ~2.0–2.1× — but, again, predominantly Russian-language and not FDA-grade.

The grading, in one place

Bottom line: these are the two genuinely well-studied anchors of the Khavinson family, but neither clears the FDA-RCT bar. Epithalon brings the most research and the only recent international in-vitro validation; Thymalin brings the longest clinical track record. Most of the human evidence for both is Russian-language and observational.

Can You Stack Them?

Yes — and unlike most “can you stack X and Y” questions on VialBase, this pairing has an actual human signal behind it, because the pineal + thymus combination is the classic Khavinson protocol. As noted above, the combined arm of the 266-patient cohort (PMID 14523363) produced the largest mortality reduction (~2.5-fold), beating either peptide alone. The vault also lists this pairing as a named convention: Epithalon appears with Thymalin (and GHK-Cu) in the “Telomere & Pineal Reset Stack” and the “DNA Repair Stack,” and with DSIP in the “Nervous System Reset Stack.” The logic is clean and complementary — a pineal/telomere/circadian peptide alongside a thymus/immune peptide, two different organs rather than two of the same, so it is reinforcement, not redundancy.

The honest caveats:

1. The combination data used Epithalamin, not synthetic Epithalon. The 2.5× result came from the natural pineal extract plus Thymalin; animal data supports the synthetic short peptides behaving like the extracts (PMID 11163623), but a head-to-head human trial of synthetic Epithalon + Thymalin specifically was not located. Read the cohort as strong support for the strategy, not proof of the synthetic-on-synthetic stack.
2. It is Russian-language, non-randomized, observational data — even the family’s best result is not an RCT.
3. No standardized combined human protocol exists. Practitioners run the two on their respective pulsed schedules (Epithalon ~5–10 mg/day × 10–20 days, 2–3×/yr; Thymalin ~10 mg/day × 5–10 days), not a single validated co-dosing regimen.

So: the pairing is the most evidence-backed stack in the entire Khavinson family — and it is still below FDA-grade. That is the honest version.

Which For Which Goal?

“Better” depends entirely on the research question. Here is the per-goal read.

The clean mental model: Epithalon = the pineal/longevity/circadian peptide; Thymalin = the thymus/immune peptide. If your interest spans both axes — long-term aging and immune resilience — the pairing is the traditional answer.

Dosing & Cycling Conventions

The following is research-use reference information, not medical advice. Both compounds follow the Khavinson “course” tradition — short, intensive pulsed cycles rather than continuous daily use, on the hypothesis that benefits persist after the course ends (attributed to epigenetic modulation), so year-round dosing is not the norm.

Epithalon reconstitution (from the compound profile): a 10 mg lyophilized vial + 2 mL bacteriostatic water = 5,000 mcg/mL; a 5 mg dose = 1.0 mL, a 10 mg dose = 2.0 mL (the full vial). A 50 mg vial + 2 mL = 25,000 mcg/mL; a 5 mg dose = 0.2 mL, a 10 mg dose = 0.4 mL. Store reconstituted material at 2–8 °C; stability ~28 days. Thymalin ships similarly as a lyophilized powder requiring reconstitution; the source profile specifies the dosing schedule above but does not give per-vial reconstitution volumes, so confirm concentration against the specific lot/SKU. There is no standardized, peer-reviewed reconstitution or per-dose protocol for this line — instructions are vendor/manufacturer-specific — so treat all figures here as research-use reference points, not validated human regimens.

Side Effects & Safety

Both are described as generally well tolerated, with the principal difference being Epithalon’s cancer-cell telomere nuance.

Key safety takeaways:

• Epithalon’s one meaningful flag is the cancer-cell ALT signal (PMID 40908429): it extended telomeres in cancer cell lines via the ALT pathway rather than telomerase. This does not indicate Epithalon causes cancer, but it supports caution in anyone with active malignancy or high cancer risk. The long-term effects of telomerase activation in humans are also not fully characterized.
• Thymalin’s profile is reassuringly quiet in the source — one of the oldest bioregulators with no significant side effects reported across decades of (primarily Russian/Eastern European) use — but “no significant effects reported” reflects a Russian clinical tradition, not FDA-grade pharmacovigilance.
• Both are research compounds, and long-term human safety beyond the established regional clinical context is under-characterized for each. Sourcing quality matters — more so for Thymalin, since a tissue-extract complex is harder to verify than a single defined synthetic sequence.

Neither compound is FDA-approved in the U.S., and neither is intended to diagnose, treat, cure, or prevent any disease.

Where to Buy

Because both compounds are sold for research purposes only and are not FDA-approved, sourcing quality and third-party testing matter more than price. With unapproved research peptides, a published Certificate of Analysis (COA) and HPLC purity/identity data are the most important quality signals — and they matter more for Thymalin than Epithalon, since a tissue-extract complex is harder to verify than a single defined synthetic sequence.

• For Epithalon (synthetic single-sequence peptide): VialBase’s recommended vendor is BioLongevity Labs, which provides research-grade material. Customer discount: 15% off with code VIALBASE.
• For Thymalin and the broader Khavinson line: Certified-Pep is a US-based research-peptide vendor that carries Khavinson-family peptides, performs third-party HPLC testing, and publishes COAs on its product pages with cold-chain shipping.

When evaluating any vendor, prioritize third-party-tested products with published, lot-specific COAs, proper lyophilization, and cold-chain handling. Confirm the COA matches the lot you receive, and always comply with the laws and regulations applicable in your jurisdiction.

Affiliate disclosure: the vendor links above are affiliate links, and VialBase may earn a commission on qualifying purchases at no additional cost to you. This does not influence our research-based editorial coverage.

Frequently Asked Questions

What is the main difference between Epithalon and Thymalin? Both are Khavinson peptide bioregulators, but they target different organs. Epithalon is a synthetic pineal tetrapeptide (Ala-Glu-Asp-Gly) studied for telomerase activation, telomere extension, and melatonin/circadian regulation. Thymalin is a natural thymus polypeptide complex studied for immune restoration and T-cell education. Epithalon is one defined sequence; Thymalin is a mixture.

Which one is better, Epithalon or Thymalin? Neither is universally better — they serve different research goals. For longevity, telomeres, sleep, or circadian reset, Epithalon is the relevant peptide. For immune restoration, recovery, or aging-related immune decline, Thymalin is. Because they target different organs (pineal vs thymus), the classic Khavinson approach actually pairs them rather than choosing one.

Can you stack Epithalon and Thymalin together? Yes — the pineal-plus-thymus pairing is the classic Khavinson protocol, and it has the strongest human signal in the family. In a 266-patient cohort, the combination cut mortality about 2.5-fold, beating either alone (PMID 14523363). The important caveat: that study used Epithalamin (the natural pineal extract), not synthetic Epithalon, and it was observational Russian-language data.

Is the science behind Epithalon and Thymalin solid? Partly. They are the two best-studied Khavinson bioregulators — Epithalon has 35+ years of research plus recent international in-vitro validation of telomerase activation, and Thymalin has decades of Russian clinical use. But neither has an FDA-registered clinical trial, and most human evidence is Russian-language and below modern FDA-grade rigor. Treat it as a plausible, regionally supported model.

Are Epithalon and Thymalin FDA-approved? No. Neither Epithalon nor Thymalin is FDA-approved for human use in the United States; both are sold for research purposes only and have no US medical indication. Both belong to the Khavinson peptide-bioregulator family with decades of clinical history in Russia and Eastern Europe, which is a different regulatory regime from the FDA. Always follow the laws applicable in your jurisdiction.

How are Epithalon and Thymalin dosed in research? Both follow short, pulsed courses rather than continuous use. Epithalon research protocols use about 5–10 mg subcutaneously daily for 10–20 days, repeated 2–3 times per year (evening preferred). Thymalin is described at about 10 mg/day for 5–10 days, with low-dose maintenance options such as 1 mg 2–3×/week. This is research-use reference information, not a prescribed human protocol.

Does Epithalon really lengthen telomeres, and does Thymalin? In a 2025 in-vitro study, Epithalon produced dose-dependent telomere extension in normal human cells via hTERT and telomerase activation (PMID 40908429) — though human telomere-length outcomes are far less established. Telomere/genomic-stability effects are mentioned for Thymalin too, but telomerase activation is Epithalon’s headline mechanism, not Thymalin’s. Neither has human telomere-length trial data.

What is the difference between Epithalon and Epithalamin (and why does it matter here)? Epithalamin is the natural pineal-gland extract; Epithalon is its synthetic tetrapeptide equivalent (Ala-Glu-Asp-Gly), built to carry the same signal. This matters because the landmark mortality-reduction cohort that is often cited for “Epithalon + Thymalin” actually used Epithalamin plus Thymalin. The synthetic peptide is designed to reproduce that effect and is supported by animal data, but the headline human number came from the natural extract.

References

Background sources for both compound profiles, dosing, stacks, and safety notes: The Ultimate Peptides Bible (2026 Edition) by Tom Ralston, the Epithalon and Thymalin compound profiles in the VialBase research library, and the associated bloodwork guides. The efficacy, mechanism, and combination claims below are cited to the primary peer-reviewed literature (PubMed), verified against the source records.

Honesty note on the evidence: Epithalon and Thymalin are the two best-supported Khavinson bioregulators, but neither has an FDA-registered randomized controlled trial. The strongest human outcome (the 266-patient mortality cohort, Ref 2) is observational, Russian-language, and used the natural pineal extract Epithalamin — not synthetic Epithalon — alongside Thymalin. Epithalon’s most rigorous modern, international evidence (Ref 5) is in-vitro, not a human telomere trial. Where a claim rests on weak, observational, or non-English-indexed sources, it is graded down in the prose rather than presented as established.

1. PMID: 12374906 — Khavinson, Neuro Endocrinol Lett, 2002. Taxonomy/design-principle monograph defining the organ-extract complexes (e.g., epithalamin, thymalin) and the shorter synthetic peptides built to reproduce them (e.g., Ala-Glu-Asp-Gly = Epitalon).
2. PMID: 14523363 — Khavinson et al., Neuro Endocrinol Lett, 2003. 266 older adults over 6–8 years; Thymalin and Epithalamin (the natural pineal extract), separately and combined, reduced mortality vs control (combination ~2.5×). The single strongest human outcome in the class — observational, Russian-language; note it used Epithalamin, not synthetic Epithalon.
3. PMID: 12577695 — Khavinson et al., Adv Gerontol, 2002. Russian-language geroprotective data underpinning the human life-extension claim.
4. PMID: 11163623 — Anisimov et al., Mech Ageing Dev, 2001. Animal evidence that the synthetic short peptides reproduce the extract effects on lifespan and tumour incidence; the bridge from Epithalamin/Thymalin extracts to their synthetic analogues.
5. PMID: 40908429 — Al-Dulaimi et al., Biogerontology, 2025. Verified; in-vitro dose-dependent telomere extension via hTERT/telomerase in normal cells, ALT in cancer lines.
6. PMID: 40493162 — Gatta et al., Stem Cell Rev Rep, 2025. Verified; antioxidant-driven tissue repair.
7. PMID: 37686182 — Linkova et al., Int J Mol Sci, 2023. Characterizes Thymalin’s active dipeptide fractions at the gene-expression level, bridging the extract and synthetic forms.

Disclosure: This article is for educational and research-use purposes only and is not medical advice. Neither Epithalon nor Thymalin is FDA-approved. VialBase may earn an affiliate commission from the vendor links above, at no additional cost to you. Consult a qualified healthcare professional before making any health decision.

JSON-LD (for <head>)

{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "MedicalWebPage",
      "@id": "https://vialbase.com/compare/epithalon-vs-thymalin#webpage",
      "url": "https://vialbase.com/compare/epithalon-vs-thymalin",
      "name": "Epithalon vs Thymalin: Differences, Research & How They Pair",
      "headline": "Epithalon vs Thymalin: Differences, Research & How They Pair",
      "description": "Epithalon vs Thymalin compared: a synthetic pineal tetrapeptide vs a thymus polypeptide complex — two Khavinson bioregulators on composition, evidence, dosing, safety, and how they pair. Both are research compounds in the US; neither is FDA-approved.",
      "inLanguage": "en",
      "lastReviewed": "2026-06-05",
      "isPartOf": {
        "@type": "WebSite",
        "name": "VialBase",
        "url": "https://vialbase.com"
      },
      "publisher": {
        "@type": "Organization",
        "name": "VialBase",
        "url": "https://vialbase.com"
      },
      "about": [
        {
          "@type": "MedicalEntity",
          "name": "Epithalon",
          "alternateName": ["Epitalon", "Epithalone", "Ala-Glu-Asp-Gly"],
          "description": "A synthetic pineal tetrapeptide (Ala-Glu-Asp-Gly, MW ~390.35 Da) developed by Professor Vladimir Khavinson as the synthetic version of epithalamin. Studied for telomerase (hTERT) activation, telomere extension, pineal/melatonin and circadian regulation, and antioxidant activity. Not FDA-approved; research use only in the United States."
        },
        {
          "@type": "MedicalEntity",
          "name": "Thymalin",
          "alternateName": "Thymus polypeptide complex",
          "description": "A natural thymus-derived polypeptide complex (not a single defined sequence) studied for thymic restoration, T-cell education, immune modulation, and anti-inflammation. One of the oldest Khavinson peptide bioregulators with a long Russian clinical track record. Not FDA-approved; research use only in the United States."
        }
      ],
      "mainEntity": {
        "@type": "MedicalGuideline",
        "name": "Epithalon vs Thymalin research-use comparison reference",
        "evidenceLevel": "https://schema.org/EvidenceLevelC",
        "guidelineSubject": [
          { "@type": "MedicalEntity", "name": "Epithalon" },
          { "@type": "MedicalEntity", "name": "Thymalin" }
        ]
      },
      "mainContentOfPage": {
        "@type": "WebPageElement",
        "speakable": {
          "@type": "SpeakableSpecification",
          "cssSelector": ["h1", "p"]
        }
      },
      "disclaimer": "Research-use and educational content only. Not medical advice. Neither Epithalon nor Thymalin is FDA-approved; both are sold for research purposes only."
    },
    {
      "@type": "FAQPage",
      "@id": "https://vialbase.com/compare/epithalon-vs-thymalin#faq",
      "mainEntity": [
        {
          "@type": "Question",
          "name": "What is the main difference between Epithalon and Thymalin?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Both are Khavinson peptide bioregulators, but they target different organs. Epithalon is a synthetic pineal tetrapeptide (Ala-Glu-Asp-Gly) studied for telomerase activation, telomere extension, and melatonin/circadian regulation. Thymalin is a natural thymus polypeptide complex studied for immune restoration and T-cell education. Epithalon is one defined sequence; Thymalin is a mixture."
          }
        },
        {
          "@type": "Question",
          "name": "Which one is better, Epithalon or Thymalin?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Neither is universally better — they serve different research goals. For longevity, telomeres, sleep, or circadian reset, Epithalon is the relevant peptide. For immune restoration, recovery, or aging-related immune decline, Thymalin is. Because they target different organs (pineal vs thymus), the classic Khavinson approach actually pairs them rather than choosing one."
          }
        },
        {
          "@type": "Question",
          "name": "Can you stack Epithalon and Thymalin together?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Yes — the pineal-plus-thymus pairing is the classic Khavinson protocol, and it has the strongest human signal in the family. In a 266-patient cohort, the combination cut mortality about 2.5-fold, beating either alone (PMID 14523363). The important caveat: that study used Epithalamin, the natural pineal extract, not synthetic Epithalon, and it was observational Russian-language data."
          }
        },
        {
          "@type": "Question",
          "name": "Is the science behind Epithalon and Thymalin solid?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Partly. They are the two best-studied Khavinson bioregulators — Epithalon has 35+ years of research plus recent international in-vitro validation of telomerase activation, and Thymalin has decades of Russian clinical use. But neither has an FDA-registered clinical trial, and most human evidence is Russian-language and below modern FDA-grade rigor. Treat it as a plausible, regionally supported model."
          }
        },
        {
          "@type": "Question",
          "name": "Are Epithalon and Thymalin FDA-approved?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "No. Neither Epithalon nor Thymalin is FDA-approved for human use in the United States; both are sold for research purposes only and have no US medical indication. Both belong to the Khavinson peptide-bioregulator family with decades of clinical history in Russia and Eastern Europe, which is a different regulatory regime from the FDA. Always follow the laws applicable in your jurisdiction."
          }
        },
        {
          "@type": "Question",
          "name": "How are Epithalon and Thymalin dosed in research?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Both follow short, pulsed courses rather than continuous use. Epithalon research protocols use about 5 to 10 mg subcutaneously daily for 10 to 20 days, repeated 2 to 3 times per year (evening preferred). Thymalin is described at about 10 mg/day for 5 to 10 days, with low-dose maintenance options such as 1 mg 2 to 3 times per week. This is research-use reference information, not a prescribed human protocol."
          }
        },
        {
          "@type": "Question",
          "name": "Does Epithalon really lengthen telomeres, and does Thymalin?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "In a 2025 in-vitro study, Epithalon produced dose-dependent telomere extension in normal human cells via hTERT and telomerase activation (PMID 40908429), though human telomere-length outcomes are far less established. Telomere and genomic-stability effects are mentioned for Thymalin too, but telomerase activation is Epithalon's headline mechanism, not Thymalin's. Neither has human telomere-length trial data."
          }
        },
        {
          "@type": "Question",
          "name": "What is the difference between Epithalon and Epithalamin, and why does it matter here?",
          "acceptedAnswer": {
            "@type": "Answer",
            "text": "Epithalamin is the natural pineal-gland extract; Epithalon is its synthetic tetrapeptide equivalent (Ala-Glu-Asp-Gly), built to carry the same signal. This matters because the landmark mortality-reduction cohort often cited for Epithalon plus Thymalin actually used Epithalamin plus Thymalin. The synthetic peptide is designed to reproduce that effect and is supported by animal data, but the headline human number came from the natural extract."
          }
        }
      ]
    },
    {
      "@type": "BreadcrumbList",
      "@id": "https://vialbase.com/compare/epithalon-vs-thymalin#breadcrumb",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://vialbase.com/"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Compare",
          "item": "https://vialbase.com/compare"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Epithalon vs Thymalin",
          "item": "https://vialbase.com/compare/epithalon-vs-thymalin"
        }
      ]
    }
  ]
}